Source:http://linkedlifedata.com/resource/pubmed/id/17478000
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2007-5-28
|
pubmed:abstractText |
The multifunctional envelope-type nano device (MEND) is a novel non-viral gene delivery system for plasmid DNA (pDNA) and oligodeoxynucleotides (ODN). We showed previously that octaarginine-modified MEND (R8-MEND) produces a high transfection activity without cytotoxicity via macropinocytosis and efficient release of a condensed DNA core to the cytosol. In the present study, we succeeded in developing an efficient method for packaging siRNA into the R8-MEND, and its silencing effect was compared with that of transfection reagent TransIT-TKO. A polycation able to condense siRNA was screened for by measuring the size and zeta-potential of complexes formed between siRNA and the polycations poly-l-lysine (PLL), stearyl octaarginine (STR-R8) and protamine. Only STR-R8 was able to condense siRNA to form nano particles (<100 nm), whereas all three polycations were able to condense pDNA or ODN. The siRNA packaged in R8-MEND inhibited luciferase activity by more than 80% in HeLa cells stably expressing luciferase. Much amount of siRNA was internalized into the cells as R8-MEND, and siRNA was effectively released from lipid envelope of MEND to cytoplasm near the nucleus. Consequently, R8-MEND can deliver condensed siRNA into cells to produce an efficient and persistent silencing effect with minimum cytotoxicity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Luciferases,
http://linkedlifedata.com/resource/pubmed/chemical/Oligopeptides,
http://linkedlifedata.com/resource/pubmed/chemical/Polylysine,
http://linkedlifedata.com/resource/pubmed/chemical/Protamines,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Small Interfering,
http://linkedlifedata.com/resource/pubmed/chemical/octaarginine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1873-4995
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
22
|
pubmed:volume |
119
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
360-7
|
pubmed:meshHeading |
pubmed-meshheading:17478000-Drug Compounding,
pubmed-meshheading:17478000-Gene Transfer Techniques,
pubmed-meshheading:17478000-HeLa Cells,
pubmed-meshheading:17478000-Humans,
pubmed-meshheading:17478000-Luciferases,
pubmed-meshheading:17478000-Microscopy, Confocal,
pubmed-meshheading:17478000-Nanostructures,
pubmed-meshheading:17478000-Oligopeptides,
pubmed-meshheading:17478000-Polylysine,
pubmed-meshheading:17478000-Protamines,
pubmed-meshheading:17478000-RNA, Small Interfering,
pubmed-meshheading:17478000-RNA Interference,
pubmed-meshheading:17478000-Transfection
|
pubmed:year |
2007
|
pubmed:articleTitle |
Octaarginine-modified multifunctional envelope-type nano device for siRNA.
|
pubmed:affiliation |
Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|